NASDAQ:BBLG | Free Cash Flow | Bone Biologics Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-10-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$804,282.00
2025-12-31-$714,762.00
2025-03-31-$926,125.00
2024-12-31-$1.35M
2024-03-31-$1.3M
2023-12-31-$2.02M
2023-03-31-$1.35M
2022-12-31-$1.95M
2022-03-31-$860,779.00
2021-12-31-$186,852.00
2021-03-31-$127,983.00
2020-12-31-$125,693.00
2020-03-31-$149,878.00
2019-12-31-$297,689.00
2019-03-31-$928,967.00
2018-12-31-$1.34M
2018-03-31-$818,875.00
2017-12-31-$931,700.00
2017-03-31-$1.01M
2016-12-31-$1.27M
2016-03-31-$2.53M
2015-12-31-$1.01M$0.00-$1.01M
2015-03-31-$491,814.00$504.00-$492,318.00
2014-12-31-$1.91M
2014-03-31-$3,016.00
2014-01-31-$1,535.00
2013-12-31-$142,259.00
2013-10-31-$632.00
2013-01-31-$30.00
2012-10-31-$6,057.00
2012-01-31$0.00
2010-10-31$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$2.69M
2024-12-31-$4.12M
2023-12-31-$9.56M
2022-12-31-$3.57M
2021-12-31-$1.23M
2020-12-31-$426,933.00
2019-12-31-$3.25M
2018-12-31-$4.1M
2017-12-31-$3.33M
2016-12-31-$7.33M
2015-12-31-$3.55M$504.00-$3.55M
2014-12-31-$2.76M$11,901.00-$2.77M
2013-12-31-$525,365.00
2013-10-31-$6,116.00
2012-10-31-$6,057.00
2011-10-31-$3,597.00
2010-10-31-$5,681.00